The pharmaceutical industry is a
fast changing environment and the due diligence (DD) process is of equally high
financial importance for seller (our-licensing) and buyer (in-licensing). With
consultants experienced on both sides, we can assist you in the evaluation of a
potential opportunity as well as in the preparation of a comprehensive package
for the successful sale of your technology or project.
We Provide Due Diligence Services for:
In-Licensing - Target evaluation
- Preliminary DD evaluation (identification of
early flags)
- Deep-fact finding in eRoom
- Formal face-to-face DD for early projects or
clinical candidates
- Identification of key safety issues and risk
assessment
- Assessment of regulatory dossier and evaluation
of current and planned regulatory strategies
- Evaluation of CMC information to determine
current status of manufacturing feasibility and future development needs
Out-Licensing - Identification of potential buyers
- Organization of DD meetings
- Preparation of a due diligence package
- Identification of key missing data
- Preparation of DD presentations
- Evaluation of current regulatory dossier and
gap analysis to assess regulatory hurdles which may impact project worth
| 